Roche Financial Statements From 2010 to 2024
| RHHBY Stock | USD 30.33 0.08 0.26% |
Check Roche Holding financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Roche main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Roche financial statements analysis is a perfect complement when working with Roche Holding Valuation or Volatility modules.
Roche |
Roche Holding Ltd OTC Stock Return On Equity Analysis
Roche Holding's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Roche Holding Return On Equity | 0.45 |
Most of Roche Holding's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Roche Holding Ltd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Roche Holding Ltd has a Return On Equity of 0.4483. This is 101.87% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on equity for all United States stocks is notably lower than that of the firm.
Roche Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Roche Holding's current stock value. Our valuation model uses many indicators to compare Roche Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Roche Holding competition to find correlations between indicators driving Roche Holding's intrinsic value. More Info.Roche Holding Ltd is currently regarded as top stock in return on equity category among related companies. It is currently regarded as top stock in return on asset category among related companies reporting about 0.33 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Roche Holding Ltd is roughly 3.05 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Roche Holding by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Roche Holding's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Roche Holding's earnings, one of the primary drivers of an investment's value.About Roche Holding Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Roche Holding income statement, its balance sheet, and the statement of cash flows. Roche Holding investors use historical funamental indicators, such as Roche Holding's revenue or net income, to determine how well the company is positioned to perform in the future. Although Roche Holding investors may use each financial statement separately, they are all related. The changes in Roche Holding's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Roche Holding's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Roche Holding Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Roche Holding. Please read more on our technical analysis and fundamental analysis pages.
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. Roche Holdings operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 100920 people.
Currently Active Assets on Macroaxis
Check out the analysis of Roche Holding Correlation against competitors. Note that the Roche Holding information on this page should be used as a complementary analysis to other Roche Holding's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Roche OTC Stock analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |